Wide Local Excision = 2cm Margin

PROCEDURE2 trials

Sponsors

Melanoma and Skin Cancer Trials Limited

Conditions

Cutaneous Melanoma by AJCC V7 StageCutaneous Melanoma, Stage II

Unknown Phase

MelmarT Melanoma Margins Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma

Active, not recruitingNCT02385214

Melanoma and Skin Cancer Trials LimitedCutaneous Melanoma by AJCC V7 Stage

Start: 2015-01-03End: 2026-08-05Updated: 2024-11-27

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

RecruitingNCT03860883

Melanoma and Skin Cancer Trials LimitedCutaneous Melanoma, Stage II

Start: 2019-12-17End: 2034-12-31Target: 2998Updated: 2024-11-27

Related Papers

Missing data and missed opportunities: Inability to perform secondary analysis of prospective randomized control trials due to missing general anesthesia data.

Journal of Clinical Oncology2025-05-28

Wise or wide (WoW) study protocol: a national, multicentre, prospective, randomised and controlled, parallel group, non-inferiority study to compare single-staged versus two-staged excisions of thin invasive (≤1.0 mm) melanoma

BMJ Open2025-04-013 citations

Management of Localized Melanoma in the Anti-PD-1 Era.

2024-06-062 citations

1 Versus 2-cm Excision Margins for pT2-pT4 Primary Cutaneous Melanoma (MelMarT): A Feasibility Study.

2018-05-3031 citations